stila illuminate and shine description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

stila illuminate and shine

Stila Styles, LLC

stila illuminate and shine


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

illuminating tinted moisturizer - shade 01

Drug Facts

Active ingredient

Purpose

Active Ingredients Purpose
Octinoxate 7.5 % sunscreen
Avobenzone 3% sunscreen
Octisalate 2% sunscreen

stila illuminate and shine Uses

Provides moderate protection against sunburn

Warnings

For external use only.

The sun may cause sunburn, premature aging of the skin, and skin cancer. Avoiding the sun, wearing protective clothing, and regular use of sunscreens over the years may reduce the chance of harmful effects.

When using this product

  • Keep out of eyes.

Stop use and ask a doctor if

Irritation occurs.

Keep out of reach of children

Directions

Apply to clean skin with fingerstips.

Inactive Ingredients

water (aqua), diethylhexyl carbonate, cyclopentasiloxane, ethylhexyl stearate, diisostearoyl polyglyceryl-3 dimer dilinoleate, glycerin, prunus amygdalus dulcis (sweet almond) oil, alumina, magnesium sulfate, microcrystalline wax/cera microcristallina, cetyl dimethicone, cyclohexasiloxane, hydrogenated castor oil, phenoxyethanol, chlorphenesin, cetyl peg/ppg10/1 dimethicone, polyglyceryl-4 isostearate, hexyl laurate, benzoic acid, butylene glycol, sorbic acid, isopropyl titanium triisostearate, tin oxide may contain (+/-) mica, titanium dioxide (ci77981), iron oxides (ci77491, ci77492, ci77499)

dist. by © stila styles, llc • los angeles, ca 90027

PRINCIPAL DISPLAY PANEL - Kit Label

stila
illuminate and shine

this exclusive set contains stila's best-selling illuminating tinted moisturizer in shade 01,
one step primecolor in kitten and illuminating finishing powder in gold

stilacosmetics.com

stila illuminate and shine

stila illuminate and shine

Octinoxate, Avobenzoate, and Octisalate KIT

Product Information

Product Type Human otc drug label Item Code (Source) NDC:76049-620
Route of Administration DEA Schedule

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:76049-620-01 1 in 1 PACKAGE, COMBINATION

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-31


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.